We are live on ! Find out more
PCVX icon

Vaxcyte
PCVX

78 hedge funds and large institutions have $1.1B invested in Vaxcyte in 2021 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 29 increasing their positions, 25 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

60% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 5

16% more repeat investments, than reductions

Existing positions increased: 29 | Existing positions reduced: 25

13% more capital invested

Capital invested by funds: $971M → $1.1B (+$124M)

4% more funds holding

Funds holding: 75 → 78 (+3)

0% more funds holding in top 10

Funds holding in top 10: 4 → 4 (0)

1.35% less ownership

Funds ownership: 84.12% → 82.77% (-1.4%)

Holders
78
Holders Change
+3
Holders Change %
+4%
% of All Funds
1.37%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
8
Increased
29
Reduced
25
Closed
5
Calls
$634K
Puts
–
Net Calls
+$634K
Net Calls Change
+$380K

Top Buyers

1
Vanguard Group
Vanguard Group
Pennsylvania
+$4.73M
2
BlackRock
BlackRock
New York
+$4.32M
3
Wellington Management Group
Wellington Management Group
Massachusetts
+$3.88M
4
Fidelity Investments
Fidelity Investments
Massachusetts
+$2.95M
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$2.7M

Top Sellers

1
State Street
State Street
Massachusetts
-$8.9M
2
TGHSA
TPG Group Holdings (SBS) Advisors
Texas
-$7.37M
3
IC
Ikarian Capital
Texas
-$3.71M
4
Voloridge Investment Management
Voloridge Investment Management
Florida
-$1.58M
5
Citigroup
Citigroup
New York
-$1.45M
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$199M +$2.95M +121,576 +2%
TGHSA
2
TPG Group Holdings (SBS) Advisors
Texas
$108M -$7.37M -304,085 -7%
A
3
Abingworth
United Kingdom
$106M – – –
Janus Henderson Group
4
Janus Henderson Group
United Kingdom
$104M -$569K -23,493 -0.6%
RCM
5
RA Capital Management
Massachusetts
$98.9M +$753K +31,057 +0.8%
Vanguard Group
6
Vanguard Group
Pennsylvania
$77.2M +$4.73M +195,238 +7%
BlackRock
7
BlackRock
New York
$64.1M +$4.32M +178,028 +8%
FM
8
Frazier Management
Washington
$58.6M – – –
MVM
9
Medicxi Ventures Management
Jersey
$47.9M – – –
PBPIA
10
Pivotal bioVenture Partners Investment Advisor
California
$35.7M – – –
State Street
11
State Street
Massachusetts
$28.8M -$8.9M -367,009 -24%
Wellington Management Group
12
Wellington Management Group
Massachusetts
$26.3M +$3.88M +160,096 +18%
O
13
OrbiMed
New York
$26.2M +$2.16M +89,265 +9%
Geode Capital Management
14
Geode Capital Management
Massachusetts
$16M +$2.7M +111,593 +22%
Northern Trust
15
Northern Trust
Illinois
$9.52M +$229K +9,455 +3%
SCM
16
Soleus Capital Management
Connecticut
$9.02M -$485K -20,000 -5%
OM
17
Opaleye Management
Massachusetts
$8.97M -$107K -4,400 -1%
IC
18
Ikarian Capital
Texas
$7.49M -$3.71M -152,999 -34%
Millennium Management
19
Millennium Management
New York
$7.14M -$832K -34,329 -11%
Goldman Sachs
20
Goldman Sachs
New York
$6.25M +$1.47M +60,709 +33%
Charles Schwab
21
Charles Schwab
California
$6.03M +$1.58M +65,145 +38%
State of Wisconsin Investment Board
22
State of Wisconsin Investment Board
Wisconsin
$4.27M +$960K +39,605 +31%
GTC
23
Ghost Tree Capital
New York
$4.06M +$364K +15,000 +10%
N
24
Nuveen
North Carolina
$3.88M -$190K -7,855 -5%
Bank of New York Mellon
25
Bank of New York Mellon
New York
$3.49M +$463K +19,092 +16%
1
2 3 4

PCVX Hedge Fund Activity: Q3 2021 in Review

78 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Vaxcyte (PCVX) for Q3 2021, worth a combined $1.1B — up 13% from $971M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new PCVX positions and 5 closed out — a net gain of 3 holders — while 29 added to existing stakes and 25 trimmed.

The largest buyer was Vanguard Group, adding an estimated $4.73M. The largest seller was State Street, cutting an estimated $8.9M.

  • 78 institutional investors held Vaxcyte (PCVX) as of Q3 2021, up from 75 in Q2 2021.
  • Funds reported $1.1B of Vaxcyte stock for Q3 2021, up 13% quarter-over-quarter.
  • 8 funds opened new Vaxcyte positions in Q3 2021 and 5 closed out, a net change of +3 holders.
  • The largest Vaxcyte buyer in Q3 2021 was Vanguard Group, an estimated $4.73M added.
  • The largest Vaxcyte seller in Q3 2021 was State Street, an estimated $8.9M sold.

Based on aggregated 13F filings for Q3 2021.